# Placebo-controlled Trial With Vitamin D to Prevent Worsening/Relieve Aromatase Inhibitor-induced Musculoskeletal Symptoms in Breast Cancer Patients

> **NCT01809171** · PHASE2,PHASE3 · TERMINATED · sponsor: **Universitaire Ziekenhuizen KU Leuven** · enrollment: 15 (actual)

## Conditions studied

- Breast Cancer
- Musculoskeletal Disease

## Interventions

- **DRUG:** Vitamin D3
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT01809171
- **Lead sponsor:** Universitaire Ziekenhuizen KU Leuven
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2013-10
- **Primary completion:** 2015-08
- **Final completion:** 2015-08
- **Target enrollment:** 15 (ACTUAL)
- **Why stopped:** Inclusion problems
- **Last updated:** 2015-10-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01809171

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01809171, "Placebo-controlled Trial With Vitamin D to Prevent Worsening/Relieve Aromatase Inhibitor-induced Musculoskeletal Symptoms in Breast Cancer Patients". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT01809171. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*